Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,598Revenue (TTM) $M113Net Margin (%)15.6Altman Z-Score9.4
Enterprise Value $M1,550EPS (TTM) $0.5Operating Margin %15.7Piotroski F-Score5
P/E(ttm)74.2Beneish M-Score-1.2Pre-tax Margin (%)10.2Higher ROA y-yY
Price/Book6.710-y EBITDA Growth Rate %--Quick Ratio10.3Cash flow > EarningsN
Price/Sales11.35-y EBITDA Growth Rate %40.6Current Ratio11.9Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %28.8ROA % (ttm)6.1Higher Current Ratio y-yY
Dividend Yield %--PEG1.9ROE % (ttm)10.2Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M43.1ROIC % (ttm)25.5Gross Margin Increase y-yN

Gurus Latest Trades with RGEN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

RGEN is held by these investors:

RGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
DAWES KAREN ADirector 2017-03-21Sell2,521$34.128.76view
Benjamin HowardVP Business Development 2017-03-20Sell12,216$34.627.19view
RYAN THOMAS F JRDirector 2017-03-20Sell4,000$34.836.55view
Snodgres JonCFO 2017-03-17Sell1,909$34.916.3view
Hunt AnthonyCEO 2016-11-28Sell5,000$33.1212.05view
RYAN THOMAS F JRDirector 2016-09-14Sell2,700$32.5813.9view
RYAN THOMAS F JRDirector 2016-06-30Sell5,000$26.639.51view
RYAN THOMAS F JRDirector 2016-06-28Sell10,000$24.5950.92view
Benjamin HowardVP Business Development 2016-05-11Sell2,889$26.7238.88view
Benjamin HowardVP Business Development 2015-06-09Sell35,000$38.14-2.7view

Quarterly/Annual Reports about RGEN:

News about RGEN:

Articles On GuruFocus.com
Repligen Announces Analyst Day and Webcast Sep 15 2017 
Repligen to Present at Baird’s 2017 Global Healthcare Conference Aug 30 2017 
Repligen to Report Second Quarter 2017 Financial Results Jul 27 2017 
Repligen Corporation and Spectrum, Inc. to Join Forces Jun 23 2017 
Repligen to Present at Jefferies’ 2017 Global Annual Healthcare Conference May 31 2017 
Repligen to Participate in 14th Annual Craig-Hallum Institutional Investor Conference May 24 2017 
Repligen to Present at Bank of America Merrill Lynch 2017 Healthcare Conference May 09 2017 
Repligen to Report First Quarter 2017 Financial Results Apr 21 2017 
Repligen Corp. Reports Operating Results (10-Q) Feb 09 2011 
Repligen Corp. Reports Operating Results (10-Q) Nov 02 2010 
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat